|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 246.00 EUR | +1.23% |
|
+2.80% | +3.10% |
| 07-14 | Where would AI lead Pharma in the long run? | ![]() |
| 07-13 | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
| Market Cap | 46.83B 53.32B 43.55B 39.96B 75.09B 5,135B 76.24B 517B 202B 2,524B 200B 196B 8,728B | P/E 2026 * |
26.4x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 46.59B 53.04B 43.32B 39.76B 74.7B 5,108B 75.85B 514B 201B 2,511B 199B 195B 8,683B | EV / Sales 2026 * |
5.45x | EV / Sales 2027 * | 4.62x |
| Free-Float |
61.59% | Yield 2026 * |
0.6% | Yield 2027 * | 0.61% |
Last Transcript: UCB
| 1 day | +1.23% | ||
| 1 week | +2.80% | ||
| Current month | -6.11% | ||
| 1 month | -3.53% | ||
| 3 months | +2.93% | ||
| 6 months | -4.43% | ||
| Current year | +3.10% |
| 1 week | 235.7 | 249.8 | |
| 1 month | 230.7 | 268.3 | |
| Current year | 223 | 289.5 | |
| 1 year | 177.7 | 289.5 | |
| 3 years | 65.4 | 289.5 | |
| 5 years | 65.4 | 289.5 | |
| 10 years | 54.84 | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 31/12/2014 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 30/06/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 30/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 31/12/2011 | |
| Director/Board Member | 67 | 31/12/2014 | |
| Director/Board Member | 56 | 23/04/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/01/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 15/01/26 | Buy | Director | 500 | 0.0003% | ||
| 15/01/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.23% | +2.80% | +37.51% | +202.14% | 53.32B | ||
| +0.63% | -3.06% | +16.18% | -9.78% | 66.74B | ||
| +10.08% | +51.80% | +51.80% | +51.80% | 48.12B | ||
| -1.32% | -7.38% | -57.63% | -57.10% | 38.25B | ||
| +0.78% | -1.84% | +52.49% | -27.01% | 29.85B | ||
| +0.84% | +0.36% | +66.93% | +85.42% | 23.51B | ||
| -5.17% | -12.54% | +58.98% | -56.04% | 21.45B | ||
| -1.21% | +1.12% | +1.98% | +170.93% | 19.97B | ||
| -0.22% | -0.95% | +61.97% | +123.78% | 16.38B | ||
| +1.31% | +3.24% | +84.01% | +152.77% | 16.47B | ||
| Average | +1.29% | -0.57% | +37.42% | +63.69% | 33.41B | |
| Weighted average by Cap. | +1.78% | +0.06% | +30.57% | +55.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.54B 9.73B 7.95B 7.29B 13.7B 937B 13.91B 94.35B 36.86B 461B 36.52B 35.73B 1,592B | 9.64B 10.98B 8.97B 8.23B 15.46B 1,057B 15.7B 106B 41.61B 520B 41.22B 40.33B 1,797B |
| Net income | 1.77B 2.02B 1.65B 1.51B 2.84B 194B 2.88B 19.55B 7.64B 95.42B 7.57B 7.4B 330B | 2.28B 2.59B 2.12B 1.94B 3.65B 250B 3.71B 25.15B 9.82B 123B 9.73B 9.52B 424B |
| Net Debt | -242M -276M -225M -207M -388M -26.56B -394M -2.67B -1.05B -13.06B -1.04B -1.01B -45.14B | -2.32B -2.65B -2.16B -1.98B -3.73B -255B -3.78B -25.66B -10.02B -125B -9.93B -9.72B -433B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | €246.00 | +1.23% | 149,516 |
| 23/07/26 | €243.00 | -0.12% | 205,984 |
| 22/07/26 | €243.30 | -0.25% | 107,748 |
| 21/07/26 | €243.90 | +2.48% | 198,029 |
| 20/07/26 | €238.00 | -0.54% | 155,998 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions




















